MedTrace Logo

PET/MRI Perfusion and CT Perfusion in Solid Tumors

NCT02314962 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2016-12-16

No results posted yet for this study

Summary

Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.

Conditions

  • CT Perfusion and MRI Perfusion in Solid Tumors

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Patrick Veit-Haibach, MD · University Hospital Zurich, Diagnostic and Interventional Radiology

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02314962 on ClinicalTrials.gov